Every Form 4 that UnitedHealth Group Incorporated (UNH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow UNH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UNH filings page.
UNITEDHEALTH GROUP INC (UNH) reported that Chief Financial Officer Wayne S. DeVeydt had 1,208.895 shares of common stock disposed of on September 2, 2026 in a transaction classified as a payment of exercise price or tax liability by delivering or withholding securities. The shares were treated as held directly, and his reported direct holdings after this transaction were 18,569.525 shares of UNH common stock. No Rule 10b5-1 trading plan is reported for this transaction.
UNITEDHEALTH GROUP INC (UNH) reported that Patrick Hugh Conway, Chief Executive Officer, Optum, sold 1,169 shares of Common Stock on 2026-08-21 in a sale described as an open market or private transaction at $390.00 per share. Following this transaction, he directly holds 15,327.797 shares of UNH common stock.
UnitedHealth Group Inc. executive Dennis Andrew Stankiewicz, Chief Accounting Officer, reported a Form 4 transaction involving Common Stock. On 2026-08-11, 233.402 shares were delivered or withheld at $402.19 per share as payment of exercise price or tax liability. Following this disposition, he directly holds 10,057.567 shares, which include shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan.
UnitedHealth Group executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported a sale of 500 shares of Common Stock on 2026-08-05. The shares were sold in a sale in open market or private transaction at $410.00 per share, for an implied value of about $205,000. Following this transaction, he directly holds 16,496.797 shares of UnitedHealth Group common stock. The Rule 10b5-1 trading-plan checkbox was not marked as affirmed for this sale.
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director John H. Noseworthy received a grant of 206 shares of common stock in the form of deferred stock units as regular quarterly compensation for board service. These units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 7,616 shares.
MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Valerie Montgomery Rice received a grant of 220 shares of Common Stock in the form of deferred stock units as regular quarterly compensation for Board service. These units are immediately vested and increase her direct holdings to 7,876 shares following the transaction.
The deferred stock units must be retained until she completes her service on the Board, aligning her compensation with longer-term director tenure rather than short-term trading.
MCNABB FREDERICK WILLIAM III reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Frederick William McNabb III received an award of 250 deferred stock units of Common Stock as regular quarterly compensation for board service. These units are immediately vested but must be held until he completes his service on the Board. Following this award, he directly holds 15,462 shares/units.
UnitedHealth Group director Scott Gottlieb reported a routine equity grant of 210 deferred stock units of common stock. The units were granted as regular quarterly compensation for his service on the board and carry no cash exercise price. After this award, he directly holds 659 deferred stock units. According to the disclosure, these units vest immediately but must be retained until he completes his service on the board, so they function as long-term, stock-based director compensation rather than a short-term trading position.
Gil Kristen reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Kristen Gil received an award of 206 shares of common stock in the form of deferred stock units. The units are granted as regular quarterly compensation for board service, are immediately vested, and must be held until Gil’s service on the Board ends. After this grant, Gil directly holds 2,617 shares, with an additional 3,800 shares held indirectly through a trust.
GARCIA PAUL R reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Paul R. Garcia reported routine equity awards and updated his indirect holdings. On July 1, 2026, he received 88 shares of common stock and 132 deferred stock units as regular quarterly compensation for board service, both at a stated price of $0.00 per share.
After these awards, Garcia directly holds 3,906 shares following the 88-share grant and 3,818 shares following the 132-unit grant, and also reports indirect holdings of 55 shares in Trust 3, 45 shares in Trust 2, and 2,146 shares in a revocable trust. The deferred stock units are immediately vested but must be retained until he completes board service.
FLYNN TIMOTHY PATRICK reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Timothy Patrick Flynn received an equity award of 225 shares of common stock-equivalent units as compensation. These deferred stock units were granted at a price of $0.00 per unit, are immediately vested, and must be held until he completes his Board service.
After this grant, Flynn directly holds 10,875 shares of UnitedHealth Group common stock. Separately, a trust associated with him indirectly holds 6,033 shares. The filing does not show any open‑market buying or selling; this is a routine compensation-related award rather than a discretionary trade.
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received an equity award of 220 deferred stock units as regular quarterly compensation for board service. These units are immediately vested but must be held until he completes his service on the Board. Following this grant, he directly holds 2,396 common shares-equivalent.
UNITEDHEALTH GROUP INC executive Erin McSweeney, EVP & Chief People Officer, acquired 48.23 shares of common stock on June 23, 2026 as a grant of dividend equivalents on outstanding restricted stock units, at a stated price of $0.00 per share. After this compensation-related award, her direct holdings increased to 15,601.153 shares of common stock. The dividend-equivalent shares are subject to the same vesting conditions as the underlying restricted stock units and are forfeited if those units do not vest.
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director John H. Noseworthy received 41 shares of Common Stock as a grant tied to dividend equivalents on vested deferred stock units. These additional shares were issued at no cost and bring his directly held position to 7,410 shares.
GARCIA PAUL R reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Paul R. Garcia reported a small equity-related compensation change. He received 13 shares of common stock on June 23, 2026 as a grant or award tied to dividend equivalents on vested deferred stock units, bringing his direct holdings to 3,686 shares of common stock.
In addition, he reported indirect holdings of 55 shares held by Trust 3, 45 shares held by Trust 2, and 2,146 shares held by a revocable trust. The new 13-share award is immediately vested and follows the same terms as the underlying deferred stock units, indicating a routine, compensation-related adjustment rather than an open‑market trade.
MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director receives additional stock-linked units through dividends. Director Valerie Montgomery Rice was granted 41 shares of Common Stock on June 23, 2026 at a stated price of $0.00 per share. These represent dividend equivalents paid on vested deferred stock units and are immediately vested under the same terms as the underlying units. Following this compensation-related award, she directly holds 7,656 shares of UnitedHealth Group common stock, indicating a routine, small-scale adjustment to her equity-based holdings rather than an open-market transaction.
UNITEDHEALTH GROUP INC director Kristen Gil reported a small equity-related update tied to existing awards. On June 23, 2026, Gil acquired 8 shares of Common Stock as a grant or award, recorded at $0.00 per share. A footnote explains these represent dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this acquisition, Gil directly holds 2,411 shares of UnitedHealth Group common stock and also has an indirect holding of 3,800 shares held by a trust.
UNITEDHEALTH GROUP INC director Scott Gottlieb reported a small share award. On the reported date, he acquired 3 shares of common stock at no cost as a grant of dividend equivalents on vested deferred stock units, bringing his direct holdings to 449 shares.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported an automatic share-based compensation adjustment. He acquired 82.488 shares of common stock at a stated price of $0.00 per share as a grant or award.
According to the footnote, these shares represent dividend equivalents paid on outstanding restricted stock units and are subject to the same vesting conditions as those units, meaning they can be forfeited if vesting is not achieved. Following this grant, Conway directly holds 16,996.797 shares of UnitedHealth common stock.
UNITEDHEALTH GROUP INC executive Noel Timothy John, Chief Executive Officer of UnitedHealthcare (UHC), reported an acquisition of 76.063 shares of common stock. These represent dividend equivalents paid on outstanding restricted stock units and carry the same vesting conditions as the underlying units. After this award, his directly held common stock position reported in this filing is 17,650.716 shares. The transaction reflects compensation-related accruals rather than an open‑market purchase.
Zaetta Christopher R reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC EVP & Chief Legal Officer Christopher R. Zaetta received 60.691 shares of common stock as a grant of dividend equivalents tied to existing restricted stock units. The award carried no purchase price and increased his directly held common stock to 15,859.84 shares.
The dividend equivalents will vest or be forfeited under the same terms as the underlying restricted stock units. A separate June 8, 2026 transfer of shares and options was exempt from Section 16 reporting under applicable SEC rules.
DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC Chief Financial Officer Wayne S. DeVeydt reported receiving a grant of 111.76 shares of common stock on June 23, 2026. The award reflects dividend equivalents paid on his outstanding restricted stock units and carries a grant price of $0.00 per share.
The dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this compensation-related award, DeVeydt directly holds 19,778.69 shares of UnitedHealth Group common stock.
HEMSLEY STEPHEN J reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director and CEO Stephen J. Hemsley reported routine equity updates. He received 46 shares of Common Stock as dividend equivalents on vested deferred stock units at $0.00 per share, raising his direct holdings to 48,098.942 shares.
Indirect holdings now include 1,006,831 shares by trusts and 356.8592 shares via a 401(k). Footnotes state that earlier large-share movements between his direct holdings and trusts were exempt transfers under Section 16 rules, reflecting internal reallocations rather than market trades.
UnitedHealth Group’s Chief Accounting Officer Dennis Andrew Stankiewicz reported a small equity-related acquisition through a Form 4. He received 50.590 shares of common stock as dividend equivalents on outstanding restricted stock units, at a stated price of $0.00 per share.
These dividend equivalents are subject to the same vesting and forfeiture terms as the underlying restricted stock units. Following this award, his directly held common stock position reported in the filing increased to 10,256.529 shares, indicating a routine, compensation-linked update rather than an open-market transaction.
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received 13 shares of common stock as dividend equivalents on vested deferred stock units. These dividend-equivalent shares are immediately vested and carry the same terms as the underlying deferred stock units. Following this compensation-related award, Baker directly holds 2,176 shares of UnitedHealth Group common stock.
UNITEDHEALTH GROUP INC director Frederick William McNabb III received a grant tied to existing deferred stock units. On this Form 4, he acquired 50 shares of Common Stock at a price of $0.00 per share as dividend equivalents on vested deferred stock units. After this award, he directly holds 15,212 shares of UnitedHealth Group common stock. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
UNITEDHEALTH GROUP INC director Timothy Patrick Flynn reported routine equity compensation activity. He acquired 61 shares of Common Stock at $0.0000 per share as a grant or award on June 23, 2026. A footnote explains these represent dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units.
After this award, Flynn directly holds 10,650 shares of Common Stock and indirectly holds 6,033 shares through a trust. The filing reflects compensation-related share accruals rather than any open-market buying or selling.
UnitedHealth Group executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported a tax-related share disposition. On June 5, 2026, 686.861 shares of common stock were withheld at $399.47 per share to cover tax obligations, leaving him with 16,914.309 directly held shares.
UnitedHealth Group executive Christopher R. Zaetta reported a small, routine tax-related share disposition. On this Form 4, he used 134.02 shares of UnitedHealth Group common stock, valued at $377.00 per share, to satisfy tax obligations. After this tax-withholding disposition, he continues to hold 16,582.149 shares directly, indicating the transaction affects only a minor portion of his overall position and does not represent an open-market sale.
UNITEDHEALTH GROUP executive Patrick Hugh Conway, Chief Executive Officer of Optum, used company shares to cover tax obligations on equity compensation. A total of 203.821 shares of common stock were disposed of at $377.92 per share, leaving him with 17,601.17 shares held directly.
UnitedHealth Group executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported an open-market sale of 800 shares of UnitedHealth Group common stock. The shares were sold at a price of $355.00 per share. After this transaction, he directly holds 17,804.991 shares of common stock.
HOOPER MICHELE J reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Michele J. Hooper received a grant of 206 deferred stock units of common stock on April 1, 2026 as regular quarterly compensation for Board service. The units are immediately vested but must be held until her Board service ends, bringing her direct holdings to 41,792 shares/units. This is a routine compensation-related equity award rather than an open-market purchase or sale.
MCNABB FREDERICK WILLIAM III reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Frederick William McNabb III received a grant of 388 deferred stock units of common stock as regular quarterly compensation for Board service. These units are immediately vested but must be held until he completes his service on the Board, and his direct holdings after the award total 15,162 shares.
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received 343 deferred stock units of Common Stock as part of his regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 2,163 shares.
Gil Kristen reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Kristen Gil received 320 deferred stock units of common stock as regular quarterly compensation for Board service. These units are immediately vested but must be held until her Board service ends. Following this grant, she holds 2,403 shares directly and 3,800 shares indirectly through a trust.
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
Director John H. Noseworthy received a grant of 320 deferred stock units of UnitedHealth Group common stock as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board. Following this award, he directly holds 7,369 shares of common stock.
UnitedHealth Group director Paul R. Garcia reported routine equity compensation awards. On April 1, 2026, he acquired 206 deferred stock units and 137 shares of common stock as regular quarterly compensation for Board service. The deferred stock units are immediately vested but must be held until he completes Board service.
After these awards, Garcia directly holds 3,673 shares of UnitedHealth Group common stock. He also has indirect holdings through trusts, including 2,146 shares by a revocable trust, 45 shares by Trust 2, and 55 shares by Trust 3, reflecting additional beneficial interests reported in this filing.
Gottlieb Scott reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Scott Gottlieb received a grant of 320 deferred stock units of Common Stock as regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board. Following this award, he directly holds 446 shares/units in total.
MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Valerie Montgomery Rice, MD, received an award of 343 deferred stock units of common stock as regular quarterly compensation for Board service. The units are immediately vested but must be held until she completes her Board service. Following this grant, she directly holds 7,615 shares/units.
FLYNN TIMOTHY PATRICK reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Timothy Patrick Flynn received a grant of 350 shares of Common Stock-equivalent deferred stock units on April 1 as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board.
Following this grant, Flynn directly holds 10,589 shares of UnitedHealth Group common stock. In addition, an indirect holding entry reflects 6,033 shares held by a trust, indicating a separate ownership structure for part of his overall position.
UNITEDHEALTH GROUP INC director Valerie Montgomery Rice received 53 shares of Common Stock as a grant. The Form 4 shows this as a compensation-related acquisition, with no purchase price. The footnote explains these are dividend equivalents on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this grant, her directly held Common Stock totals 7,272 shares.
UNITEDHEALTH GROUP INC Chief Financial Officer Wayne S. DeVeydt reported an automatic stock-based award rather than a market trade. He acquired 149.989 shares of common stock at a stated price of $0.0000 per share, increasing his direct holdings to 19,666.93 shares.
According to the footnote, these shares represent dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest, making this a routine compensation-related accrual rather than an open-market purchase or sale.
UNITEDHEALTH GROUP INC Chief Accounting Officer Dennis Andrew Stankiewicz reported an acquisition of common stock tied to existing equity awards. On March 17, 2026, he received 68.058 shares of common stock at no cost as dividend equivalents on outstanding restricted stock units, which are subject to the same vesting conditions and are forfeited if the underlying units do not vest. Following this award, his directly held common stock position increased to 10,205.939 shares, indicating a routine compensation-related update rather than an open-market trade.
UnitedHealth Group director Paul R. Garcia received an equity-based award linked to existing deferred stock units. On March 17, 2026, he acquired 16 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units that are immediately vested and subject to the same terms as the underlying units.
Following this grant, Garcia directly holds 3,330 shares of UnitedHealth Group common stock. He also has indirect holdings reported through a revocable trust and additional trusts, reflecting shares held in estate-planning vehicles rather than through open‑market transactions.
UNITEDHEALTH GROUP INC director John H. Noseworthy received 52 shares of common stock as a grant tied to dividend equivalents on vested deferred stock units. The shares were acquired at no cost, are immediately vested, and follow the same terms as the underlying deferred stock units. After this award, he directly holds 7,049 shares of common stock.
UNITEDHEALTH GROUP INC executive Christopher R. Zaetta received additional common stock linked to existing equity awards. On March 17, 2026, he acquired 89.629 shares of Common Stock at a stated price of $0.00 per share, reported as a grant or award acquisition.
The footnote explains this represents dividend equivalents paid on outstanding restricted stock units. These dividend equivalents follow the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. After this transaction, Zaetta directly holds 16,716.169 shares of Common Stock.
UNITEDHEALTH GROUP INC executive Timothy John Noel, Chief Executive Officer of UnitedHealthcare, received an acquisition of 102.329 shares of common stock as of March 17, 2026. These shares represent dividend equivalents on outstanding restricted stock units and are granted at no cash cost to him.
After this award, his directly held common stock position reported in this filing increased to 17,574.653 shares. The dividend equivalents are subject to the same vesting conditions as the underlying restricted stock units and will be forfeited if those units do not vest, making this a routine, compensation-related equity accrual rather than an open‑market purchase.
UNITEDHEALTH GROUP INC director Frederick William McNabb III reported an automatic share-based compensation event. He acquired 64 shares of common stock on March 17, 2026 with a reported price of $0.0000 per share, described as dividend equivalents on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units. After this credit, his directly held common stock position increased to 14,774 shares, reflecting a small, routine adjustment rather than an open-market purchase.
UnitedHealth Group director Timothy Patrick Flynn reported a small stock award tied to existing deferred compensation. On March 17, 2026, he acquired 79 shares of UnitedHealth common stock at $0.0000 per share as dividend equivalents on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. Following this grant, his direct holdings total 10,239 shares of common stock, and he also holds 6,033 shares indirectly through a trust.
HEMSLEY STEPHEN J reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director and CEO Stephen J. Hemsley received an award of 61 shares of common stock on March 17, 2026. This was reported as a grant or award of dividend equivalents on vested deferred stock units at a stated price of $0.0000 per share, and the dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units.
After this transaction, Hemsley directly holds 362,628.942 shares of common stock. He also has indirect holdings of 355.091 shares through a 401(k) plan and 692,255 shares held by trusts, which include 10,380 shares previously held directly and contributed to the trusts on January 29, 2026 in a transaction noted as exempt from reporting pursuant to Rule 16a-13.